96 related articles for article (PubMed ID: 31747139)
1. A community-based lung cancer rapid tissue donation protocol provides high-quality drug-resistant specimens for proteogenomic analyses.
Boyle TA; Quinn GP; Schabath MB; Muñoz-Antonia T; Saller JJ; Duarte LF; Hair LS; Teer JK; Chiang DY; Leary R; Wong CC; Savchenko A; Singh AP; Charette L; Mendell K; Gorgun G; Antonia SJ; Chiappori AA; Creelan BC; Gray JE; Haura EB
Cancer Med; 2020 Jan; 9(1):225-237. PubMed ID: 31747139
[TBL] [Abstract][Full Text] [Related]
2. Genomic landscape of metastatic lung adenocarcinomas from large-scale clinical sequencing.
Li D; Huang Y; Cai L; Wu M; Bao H; Xu Y; Wei Y; Wu S; Wu X; Shao Y; Zhao W; Lv G; Huang S; Zhang T; Shi Y
Neoplasia; 2021 Dec; 23(12):1204-1212. PubMed ID: 34735995
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Pathological Characteristics and Prognosis of Lung Adenocarcinoma With High-Grade Fetal Features: A Retrospective Analysis.
Gu Y; Zhang S; Liang X; Zhao H; Li X; Lu J
Int J Surg Pathol; 2024 Jun; 32(4):667-678. PubMed ID: 37488988
[TBL] [Abstract][Full Text] [Related]
4. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.
Gillette MA; Satpathy S; Cao S; Dhanasekaran SM; Vasaikar SV; Krug K; Petralia F; Li Y; Liang WW; Reva B; Krek A; Ji J; Song X; Liu W; Hong R; Yao L; Blumenberg L; Savage SR; Wendl MC; Wen B; Li K; Tang LC; MacMullan MA; Avanessian SC; Kane MH; Newton CJ; Cornwell M; Kothadia RB; Ma W; Yoo S; Mannan R; Vats P; Kumar-Sinha C; Kawaler EA; Omelchenko T; Colaprico A; Geffen Y; Maruvka YE; da Veiga Leprevost F; Wiznerowicz M; Gümüş ZH; Veluswamy RR; Hostetter G; Heiman DI; Wyczalkowski MA; Hiltke T; Mesri M; Kinsinger CR; Boja ES; Omenn GS; Chinnaiyan AM; Rodriguez H; Li QK; Jewell SD; Thiagarajan M; Getz G; Zhang B; Fenyö D; Ruggles KV; Cieslik MP; Robles AI; Clauser KR; Govindan R; Wang P; Nesvizhskii AI; Ding L; Mani DR; Carr SA;
Cell; 2020 Jul; 182(1):200-225.e35. PubMed ID: 32649874
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry for predictive biomarkers in non-small cell lung cancer.
Mino-Kenudson M
Transl Lung Cancer Res; 2017 Oct; 6(5):570-587. PubMed ID: 29114473
[TBL] [Abstract][Full Text] [Related]
6.
Mender I; Batten K; Peyton M; Vemula A; Cornelius C; Girard L; Gao B; Minna JD; Shay JW
Cancer Res; 2020 Mar; 80(5):929-936. PubMed ID: 31948943
[TBL] [Abstract][Full Text] [Related]
7. Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance.
Gonzalez de Castro D; Clarke PA; Al-Lazikani B; Workman P
Clin Pharmacol Ther; 2013 Mar; 93(3):252-9. PubMed ID: 23361103
[TBL] [Abstract][Full Text] [Related]
8. Lung Cancer Biomarkers.
Villalobos P; Wistuba II
Hematol Oncol Clin North Am; 2017 Feb; 31(1):13-29. PubMed ID: 27912828
[TBL] [Abstract][Full Text] [Related]
9. Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models.
Pisapia DJ; Salvatore S; Pauli C; Hissong E; Eng K; Prandi D; Sailer VW; Robinson BD; Park K; Cyrta J; Tagawa ST; Kossai M; Fontugne J; Kim R; Sigaras A; Rao R; Pancirer D; Faltas B; Bareja R; Molina AM; Nanus DM; Rajappa P; Souweidane MM; Greenfield J; Emde AK; Robine N; Elemento O; Sboner A; Demichelis F; Beltran H; Rubin MA; Mosquera JM
JCO Precis Oncol; 2017; 2017():. PubMed ID: 29333526
[TBL] [Abstract][Full Text] [Related]
10. Pediatric Postmortem Tissue Donation in the Confines of a Pandemic: A Model of Collaboration.
Arias-Stella EU; Campbell C; Pisapia DJ; Cocito C; McThenia S; Degliuomini M; Greenfield JP; Khakoo Y
Pediatr Neurol; 2023 Nov; 148():138-141. PubMed ID: 37713977
[TBL] [Abstract][Full Text] [Related]
11. Cancer biology as revealed by the research autopsy.
Iacobuzio-Donahue CA; Michael C; Baez P; Kappagantula R; Hooper JE; Hollman TJ
Nat Rev Cancer; 2019 Dec; 19(12):686-697. PubMed ID: 31519982
[TBL] [Abstract][Full Text] [Related]
12. Postmortem brain donations vs premortem surgical resections for glioblastoma research: viewing the matter as a whole.
Griffin CP; Paul CL; Alexander KL; Walker MM; Hondermarck H; Lynam J
Neurooncol Adv; 2022; 4(1):vdab168. PubMed ID: 35047819
[TBL] [Abstract][Full Text] [Related]
13. Reviving the Autopsy for Modern Cancer Evolution Research.
Robb TJ; Tse R; Blenkiron C
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33499137
[TBL] [Abstract][Full Text] [Related]
14. Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program.
Geukens T; De Schepper M; Van Den Bogaert W; Van Baelen K; Maetens M; Pabba A; Mahdami A; Leduc S; Isnaldi E; Nguyen HL; Bachir I; Hajipirloo M; Zels G; Van Cauwenberge J; Borremans K; Vandecaveye V; Weynand B; Vermeulen P; Leucci E; Baietti MF; Sflomos G; Battista L; Brisken C; Derksen PWB; Koorman T; Visser D; Scheele CLGJ; Thommen DS; Hatse S; Fendt SM; Vanderheyden E; Van Brussel T; Schepers R; Boeckx B; Lambrechts D; Marano G; Biganzoli E; Smeets A; Nevelsteen I; Punie K; Neven P; Wildiers H; Richard F; Floris G; Desmedt C
NPJ Breast Cancer; 2024 Apr; 10(1):31. PubMed ID: 38658604
[TBL] [Abstract][Full Text] [Related]
15. Bayesian approach to interpreting somatic cancer sequencing data: a case in point.
Yoon JY; Rosenbaum JN; Vergara N; Cohen RB; Wilson RB
J Clin Pathol; 2020 Aug; ():. PubMed ID: 32855180
[TBL] [Abstract][Full Text] [Related]
16. Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA Assay.
Clifton K; Rich TA; Parseghian C; Raymond VM; Dasari A; Pereira AAL; Willis J; Loree JM; Bauer TM; Chae YK; Sherrill G; Fanta P; Grothey A; Hendifar A; Henry D; Mahadevan D; Nezami MA; Tan B; Wainberg ZA; Lanman R; Kopetz S; Morris V
JCO Precis Oncol; 2019; 3():. PubMed ID: 33015522
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of rebiopsy among patients with epidermal growth factor receptor-mutant lung adenocarcinoma in a real-world clinical setting.
Nam Y; Kim HC; Kim YC; Jang SH; Lee KY; Lee SY; Lee SH; Lee SY; Yoon SH; Ryu JS; Jang TW; Chang YS; Kim SJ; Park CK; Lee JE; Jung CY; Choi CM
Thorac Cancer; 2021 Mar; 12(6):890-898. PubMed ID: 33529490
[TBL] [Abstract][Full Text] [Related]
18. Genomic landscape of acquired resistance to third-generation EGFR tyrosine kinase inhibitors in EGFR T790M-mutant non-small cell lung cancer.
Lee J; Kim HS; Lee B; Kim HK; Sun JM; Ahn JS; Ahn MJ; Park K; Lee SH
Cancer; 2020 Jun; 126(11):2704-2712. PubMed ID: 32154925
[TBL] [Abstract][Full Text] [Related]
19. Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer.
Perez BA; Kim S; Wang M; Karimi AM; Powell C; Li J; Dilling TJ; Chiappori A; Latifi K; Rose T; Lannon A; MacMillan G; Saller J; Grass GD; Rosenberg S; Gray J; Haura E; Creelan B; Tanvetyanon T; Saltos A; Shafique M; Boyle TA; Schell MJ; Conejo-Garcia JR; Antonia SJ
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):425-435. PubMed ID: 33002543
[TBL] [Abstract][Full Text] [Related]
20. Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing.
Sinjab A; Han G; Treekitkarnmongkol W; Hara K; Brennan PM; Dang M; Hao D; Wang R; Dai E; Dejima H; Zhang J; Bogatenkova E; Sanchez-Espiridion B; Chang K; Little DR; Bazzi S; Tran LM; Krysan K; Behrens C; Duose DY; Parra ER; Raso MG; Solis LM; Fukuoka J; Zhang J; Sepesi B; Cascone T; Byers LA; Gibbons DL; Chen J; Moghaddam SJ; Ostrin EJ; Rosen D; Heymach JV; Scheet P; Dubinett SM; Fujimoto J; Wistuba II; Stevenson CS; Spira A; Wang L; Kadara H
Cancer Discov; 2021 Oct; 11(10):2506-2523. PubMed ID: 33972311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
